Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2018, Article ID 9231031, 8 pages
https://doi.org/10.1155/2018/9231031
Research Article

Importance of High-Risk Human Papillomavirus Infection Detection in Female Renal Transplant Recipients in the First Year after Transplantation

1August Kirchenstein Institute of Microbiology and Virology, Riga Stradins University, Riga, Latvia
2Gynecology and Maternity Unit, Pauls Stradins Clinical University Hospital, Riga, Latvia
3Scientific Laboratory of Transplantology, Riga Stradins University, Riga, Latvia

Correspondence should be addressed to Maksims Cistjakovs; vl.usr@svokajtsic.smiskam

Received 24 September 2018; Revised 18 November 2018; Accepted 25 November 2018; Published 6 December 2018

Academic Editor: Susan Cu-Uvin

Copyright © 2018 Maksims Cistjakovs et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Bruni, M. Diaz, X. Castellsagué, E. Ferrer, F. X. Bosch, and S. De Sanjosé, “Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings,” The Journal of Infectious Diseases, vol. 202, no. 12, pp. 1789–1799, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Vaccarella, S. Franceschi, D. Zaridze et al., “Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017–40: a population-based study,” The Lancet Oncology, vol. 17, no. 10, pp. 1445–1452, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Patel, K. Pčolkina, K. Strazdina et al., “Awareness of HPV infection and attitudes toward HPV vaccination among Latvian adolescents,” International Journal of Gynecology & Obstetrics, vol. 137, no. 2, pp. 138–144, 2017. View at Publisher · View at Google Scholar
  4. E. M. Burd, “Human papillomavirus and cervical cancer,” Clinical Microbiology Reviews, vol. 16, no. 1, pp. 1–17, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Muñoz, F. X. Bosch, S. De Sanjosé et al., “Epidemiologic classification of human papillomavirus types associated with cervical cancer,” The New England Journal of Medicine, vol. 348, no. 6, pp. 518–527, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. F. Coscia, R. Monno, A. Ballini et al., “Human papilloma virus (HPV) genotypes prevalence in a region of South Italy (Apulia),” Annali dell'Istituto Superiore di Sanità, vol. 51, pp. 248–251, 2015. View at Google Scholar
  7. S. A. Brendle, S. M. Bywaters, and N. D. Christensen, “Pathogenesis of Infection by Human Papillomavirus,” in Human Papillomavirus, vol. 45 of Current Problems in Dermatology, pp. 47–57, S. KARGER AG, Basel, 2014. View at Publisher · View at Google Scholar
  8. J. F. Buell, T. G. Gross, and E. S. Woodle, “Malignancy after transplantation,” Transplantation, vol. 80, no. 2, pp. S254–S264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Lutz and U. Heemann, “Tumours after kidney transplantation,” Current Opinion in Urology, vol. 13, no. 2, pp. 105–109, 2003. View at Publisher · View at Google Scholar
  10. O. Genzer, S. E. El-Sayegh, M. J. Kleiner, and M. R. Castellanos, “Male human papillomavirus infection post-kidney transplant: an overlooked disease,” Transplantation Research, vol. 1, no. 1, p. 21, 2012. View at Publisher · View at Google Scholar
  11. K. A. P. Meeuwis, L. B. Hilbrands, J. Inthout et al., “Cervicovaginal HPV infection in female renal transplant recipients: An observational, self-sampling based, cohort study,” American Journal of Transplantation, vol. 15, no. 3, pp. 723–733, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Hinten, L. B. Hilbrands, K. A. P. Meeuwis et al., “Reactivation of Latent HPV Infections After Renal Transplantation,” American Journal of Transplantation, vol. 17, no. 6, pp. 1563–1573, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. A.-M. Vandamme, K. Fransen, L. Debaisieux et al., “Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin,” Journal of Virological Methods, vol. 51, no. 2-3, pp. 305–316, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Şahiner, A. Kubar, R. Gümral et al., “Efficiency of MY09/11 consensus PCR in the detection of multiple HPV infections,” Diagnostic Microbiology and Infectious Disease, vol. 80, no. 1, pp. 43–49, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Stanley, “Immunobiology of HPV and HPV vaccines,” Gynecologic Oncology, vol. 109, supplement 2, pp. S15–S21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Skiba, G. Mehlhorn, P. A. Fasching, M. W. Beckmann, and S. Ackermann, “Prognostic significance of serum antibodies to HPV-16 L1 virus-like particles in patients with invasive cervical cancer,” Anticancer Reseach, vol. 26, no. 6 C, pp. 4921–4926, 2006. View at Google Scholar · View at Scopus
  17. M. A. Stanley, M. R. Pett, and N. Coleman, “HPV: from infection to cancer,” Biochemical Society Transactions, vol. 35, no. 6, pp. 1456–1460, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Poljak, K. Seme, P. J. Maver et al., “Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in central and Eastern Europe,” Vaccine, vol. 31, no. 7, pp. H59–H70, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. H. Hibma, “The immune response to papillomavirus during infection persistence and regression,” The Open Virology Journal, vol. 6, no. 1, pp. 241–248, 2012. View at Publisher · View at Google Scholar
  20. N. Reusser, C. Downing, J. Guidry, and S. Tyring, “HPV carcinomas in immunocompromised patients,” Journal of Clinical Medicine, vol. 4, no. 2, pp. 260–281, 2015. View at Publisher · View at Google Scholar
  21. H. K. Larsen, L. T. Thomsen, M. Haedersdal, C. Dehlendorff, S. Schwartz Sørensen, and S. K. Kjaer, “Risk of genital warts in renal transplant recipients-A registry-based, prospective cohort study,” American Journal of Transplantation, 2018. View at Publisher · View at Google Scholar
  22. M. T. Van Leeuwen, A. C. Webster, M. R. E. McCredie et al., “Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: Population based retrospective cohort study,” BMJ, vol. 340, no. 7744, article no. c570, p. 463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. R. Sharif, Z. Chitsazian, M. Moosavian et al., “Immune disorders in hemodialysis patients,” Iranian Journal of Kidney Diseases, vol. 9, no. 2, pp. 84–96, 2015. View at Google Scholar · View at Scopus
  24. “Role of Innate Immunity against Human Papillomavirus (HPV) Infections and Effect of Adjuvants in Promoting Specific Immune Response,” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856406/, 2018.
  25. D. Szubińska-Lelonkiewicz, M. Osiak, P. Wychowański, M. Siewert-Gutowska, and P. Fiedor, “Frequency of human papilloma virus occurrence among pathological changes of the oral cavity in kidney allotransplant recipients undergoing long-term pharmacological immunosuppressive therapy,” Transplantation Proceedings, vol. 50, no. 6, pp. 1878–1880, 2018. View at Publisher · View at Google Scholar
  26. F. Islami, J. Ferlay, J. Lortet-Tieulent, F. Bray, and A. Jemal, “International trends in anal cancer incidence rates,” International Journal of Epidemiology, vol. 46, pp. 924–938, 2017. View at Publisher · View at Google Scholar
  27. P. E. Gravitt and R. L. Winer, “Natural history of HPV infection across the lifespan: Role of viral latency,” Viruses, vol. 9, no. 10, article no. 267, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Stanley, “HPV - immune response to infection and vaccination,” Infectious Agents and Cancer, vol. 5, no. 1, p. 19, 2010. View at Publisher · View at Google Scholar